Cargando…
Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
Cancer immunotherapy has drawn much attention because it can restart the recognition and killing function of the immune system to normalize the antitumor immune response. However, the role of radiotherapy and chemotherapy in cancer treatment cannot be ignored. Due to cancer heterogeneity, combined t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911251/ https://www.ncbi.nlm.nih.gov/pubmed/36778203 http://dx.doi.org/10.1155/2023/7530794 |
_version_ | 1784884953533644800 |
---|---|
author | Li, Qian Lei, Xu Zhu, Jing Zhong, Yanping Yang, Junjie Wang, Jincheng Tan, Huabing |
author_facet | Li, Qian Lei, Xu Zhu, Jing Zhong, Yanping Yang, Junjie Wang, Jincheng Tan, Huabing |
author_sort | Li, Qian |
collection | PubMed |
description | Cancer immunotherapy has drawn much attention because it can restart the recognition and killing function of the immune system to normalize the antitumor immune response. However, the role of radiotherapy and chemotherapy in cancer treatment cannot be ignored. Due to cancer heterogeneity, combined therapy has become a new trend, and its efficacy has been confirmed in many studies. This review discussed the clinical implications and the underlying mechanisms of cancer immunotherapy in combination with radiotherapy or chemotherapy, offering an outline for clinicians as well as inspiration for future research. |
format | Online Article Text |
id | pubmed-9911251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99112512023-02-10 Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications Li, Qian Lei, Xu Zhu, Jing Zhong, Yanping Yang, Junjie Wang, Jincheng Tan, Huabing Oxid Med Cell Longev Review Article Cancer immunotherapy has drawn much attention because it can restart the recognition and killing function of the immune system to normalize the antitumor immune response. However, the role of radiotherapy and chemotherapy in cancer treatment cannot be ignored. Due to cancer heterogeneity, combined therapy has become a new trend, and its efficacy has been confirmed in many studies. This review discussed the clinical implications and the underlying mechanisms of cancer immunotherapy in combination with radiotherapy or chemotherapy, offering an outline for clinicians as well as inspiration for future research. Hindawi 2023-02-02 /pmc/articles/PMC9911251/ /pubmed/36778203 http://dx.doi.org/10.1155/2023/7530794 Text en Copyright © 2023 Qian Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Li, Qian Lei, Xu Zhu, Jing Zhong, Yanping Yang, Junjie Wang, Jincheng Tan, Huabing Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications |
title | Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications |
title_full | Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications |
title_fullStr | Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications |
title_full_unstemmed | Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications |
title_short | Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications |
title_sort | radiotherapy/chemotherapy-immunotherapy for cancer management: from mechanisms to clinical implications |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911251/ https://www.ncbi.nlm.nih.gov/pubmed/36778203 http://dx.doi.org/10.1155/2023/7530794 |
work_keys_str_mv | AT liqian radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications AT leixu radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications AT zhujing radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications AT zhongyanping radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications AT yangjunjie radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications AT wangjincheng radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications AT tanhuabing radiotherapychemotherapyimmunotherapyforcancermanagementfrommechanismstoclinicalimplications |